Gomm S A, Keaney N P, Winsey N J, Stretton T B
Thorax. 1980 Jul;35(7):552-6. doi: 10.1136/thx.35.7.552.
A double-blind within-patient investigation was performed to determine whether the interposition of an extension tube (10 cm length X 3.2 cm diameter) between a metered dose inhaler and the mouth alters the bronchodilator efficacy of terbutaline sulphate. On two consecutive study days 14 adult patients with stable reversible airways obstruction inhaled a cumulative dose of 500 micrograms of terbutaline which was delivered from a metered dose inhaler with or without the extension tube attached and received placebo in a similar manner. The drug was inhaled in doses of 125, 125, and 250 micrograms at 20 minutes intervals. The following measurements were made: forced expiratory volume in one second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR), thoracic gas volume (TGV), and specific airways conductance (sGaw). These were done immediately before and at five and 15 minute intervals after each dose, and were repeated 90, 120, 180, 240, and 300 minutes after the first inhalation of terbutaline. Administration of terbutaline with and without an extension tube achieved significant bronchodilation at all dose levels in all respiratory variables (p < 0.001). There was no statistically significant difference in FEV1, FVC, PEFR, and sGaw values at any time or dose level with either method of administration. The use of the extension tube did not impair the efficacy or duration of action of inhaled terbutaline.
进行了一项双盲患者自身对照研究,以确定在定量气雾剂与口腔之间插入一根延长管(长度10厘米,直径3.2厘米)是否会改变硫酸特布他林的支气管扩张疗效。在连续两个研究日,14名患有稳定可逆性气道阻塞的成年患者吸入累积剂量为500微克的特布他林,该剂量由连接或未连接延长管的定量气雾剂提供,并以类似方式给予安慰剂。药物以125微克、125微克和250微克的剂量,每隔20分钟吸入一次。进行了以下测量:一秒用力呼气容积(FEV1)、用力肺活量(FVC)、呼气峰值流速(PEFR)、肺总量(TGV)和比气道传导率(sGaw)。在每次给药前以及给药后5分钟和15分钟时进行测量,并在首次吸入特布他林后90、120、180、240和300分钟重复测量。无论是否使用延长管,在所有剂量水平下,所有呼吸变量中特布他林的给药均实现了显著的支气管扩张(p < 0.001)。两种给药方法在任何时间或剂量水平下,FEV1, FVC, PEFR和sGaw值均无统计学显著差异。使用延长管不会损害吸入特布他林的疗效或作用持续时间。